RFK Jr's FDA to study mifepristone safety

Created at 5 Jun · 16:38 UTC1 source↑ Market-relevant

IN SHORT

Robert F. Kennedy Jr.'s FDA plans to study the safety of the abortion pill mifepristone, despite its availability for over 25 years. Approximately 7.5 million women have used the medication during this period.

Key Numbers

7.5 millionwomen who have taken mifepristone

25 yearstime mifepristone has been on the market

Who's Involved

Robert F. Kennedy Jr.

Appointed head of the FDA

FDA

U.S. Food and Drug Administration

Key facts

RFK Jr.'s FDA plans to study the safety of mifepristone.
Mifepristone has been on the market for over 25 years.
Around 7.5 million women have used the pill.

The Food and Drug Administration (FDA), under the leadership of Robert F. Kennedy Jr., is reportedly planning to conduct a study on the safety of the abortion pill mifepristone. This move comes despite the drug having been available on the market for more than two and a half decades. Over the past 25 years, an estimated 7.5 million women have utilized the pill. The decision to re-evaluate the safety of a medication with a long history of use has raised questions.

↳ Why This Matters

This potential re-evaluation of mifepristone's safety by the FDA could impact access to reproductive healthcare services and signals a shift in regulatory approach under new leadership.

FREQUENTLY ASKED

The study is reportedly planned by the FDA under the leadership of Robert F. Kennedy Jr.

Mifepristone has been on the market for over 25 years.

Approximately 7.5 million women have taken the pill over the past 25 years.

What Happens Next

01The FDA is expected to announce the details and timeline for the mifepristone safety study.

RFK Jr's FDA to study mifepristone safety

PiQ Daily

Key facts

RFK Jr's FDA to study mifepristone safety

PiQ Daily

Key facts

Get the newsletter.